StevenMJonesMD

Anatomic Pathology, Clinical Pathology

Physician

Dr. Jones is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

University of New Mexico School of MedicineResidency, Pathology-Anatomic and Clinical, 1978 - 1982
Indiana University School of MedicineClass of 1978

PubMed

Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV.
O'Dowd, H.,Shannon, D. E.,Chandupatla, K. R.,Dixit, V.,Engtrakul, J. J.,Ye, Z.,Jones, S. M.,O'Brien, C. F.,Nicolau, D. P.,Tessier, P. R.,Crandon, J. L.,Song, B.,Macike...> ;ACS Med Chem Lett. 2015 Jul 21
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections.
Locher, C. P.,Jones, S. M.,Hanzelka, B. L.,Perola, E.,Shoen, C. M.,Cynamon, M. H.,Ngwane, A. H.,Wiid, I. J.,van Helden, P. D.,Betoudji, F.,Nuermberger, E. L.,Thomson, ...> ;Antimicrob. Agents Chemother.. 2014 Dec 24
The Efflux Pump Inhibitor Timcodar (VX-853) Improves the Potency of Anti-Mycobacterial Agents.
Grossman, T. H.,Shoen, C. M.,Jones, S. M.,Jones, P. L.,Cynamon, M. H.,Locher, C. P.> ;Antimicrob. Agents Chemother.. 2014 Dec 24